Pliant Therapeutics - Stock Price History | PLRX

Historical daily share price chart and data for Pliant Therapeutics since 2021 adjusted for splits. The latest closing stock price for Pliant Therapeutics as of September 27, 2021 is 18.15.
  • The all-time high Pliant Therapeutics stock closing price was 40.23 on March 25, 2021.
  • The Pliant Therapeutics 52-week high stock price is 43.92, which is 142% above the current share price.
  • The Pliant Therapeutics 52-week low stock price is 17.00, which is 6.3% below the current share price.
  • The average Pliant Therapeutics stock price for the last 52 weeks is 27.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pliant Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 25.2351 21.3000 35.2600 19.8900 22.7200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.652B $0.042B
Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29